Protagonist Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
PTGX Nasdaq 8731 https://www.protagonist-inc.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Protagonist Therapeutics Inc

Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines - Sep 10th, 2024 5:17 pm
Despite shrinking by US$82m in the past week, Protagonist Therapeutics (NASDAQ:PTGX) shareholders are still up 188% over 5 years - Sep 9th, 2024 11:57 am
Protagonist Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024 - Sep 3rd, 2024 11:30 am
Protagonist Therapeutics (PTGX) Reports Q2 Loss, Misses Revenue Estimates - Aug 6th, 2024 12:20 pm
Protagonist Therapeutics: Q2 Earnings Snapshot - Aug 6th, 2024 11:18 am
Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update - Aug 6th, 2024 11:00 am
RETRANSMISSION: Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific Reports - Aug 1st, 2024 12:00 pm
Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific Reports - Aug 1st, 2024 11:00 am
Protagonist Announces Appointment of Newman Yeilding, M.D. as Chief Scientific Advisor - Jul 31st, 2024 1:15 pm
Protagonist Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2024 - Jul 22nd, 2024 11:00 am
Protagonist Therapeutics (PTGX) is on the Move, Here's Why the Trend Could be Sustainable - Jul 18th, 2024 12:50 pm
3 Growth Stocks No One Is Watching (But They Should Be) - Jul 11th, 2024 10:00 am
Protagonist Therapeutics Surges On Plans To Join S&P SmallCap 600 - Jun 28th, 2024 8:07 pm
Protagonist Therapeutics Set to Join S&P SmallCap 600 - Jun 27th, 2024 9:44 pm
Is Protagonist Therapeutics, Inc. (PTGX) a Good Healthcare Stock to Buy? - Jun 27th, 2024 5:43 pm
We Think Some Shareholders May Hesitate To Increase Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) CEO Compensation - Jun 15th, 2024 12:46 pm
Protagonist Reports Updated Long Term Results from Rusfertide Phase 2 REVIVE Study at the EHA2024 Congress Showing Durable Hematocrit Control - Jun 14th, 2024 7:00 am
Has Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - Jun 9th, 2024 2:17 pm
The 3 Best Biotech Stocks to Buy in June 2024 - Jun 5th, 2024 5:35 pm
Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2024 - May 31st, 2024 11:30 am